UNH UnitedHealth Group Incorporated Common Stock (DE)
关于 UnitedHealth Group Incorporated Common Stock (DE) 公司概况(来自维基百科)
聯合健康集團 是全球營業額第二大的健康保險及衛生資訊科技公司,總部設在美國明尼蘇達州明尼托卡。該公司於2020年财富世界500强公司中排名第7。《财富杂志》評選聯合健保為美國保險和管理式照護公司中最受敬重的健康保險公司第一名。
阅读更多
聯合健康集團(英語:UnitedHealth Group, NYSE:UNH)是全球營業額第二大的健康保險及衛生資訊科技公司,總部設在美國明尼蘇達州明尼托卡。該公司於2020年财富世界500强公司中排名第7。《财富杂志》評選聯合健保為美國保險和管理式照護公司中最受敬重的健康保險公司第一名。
2015年3月30日,聯合健康集團旗下的卧騰(Optum)同意以大約128億美元的價格收購藥物福利管理公司Catamaran Corp。
聯合健康集團旗下有五大公司:
聯合牛津健康保險團體與個人計劃(UnitedHealthcare Employer and Individual)
聯合牛津健康保險聯邦政府長者計劃(UnitedHealthcare Medicare and Retirement)
聯合健康保險州政府補助計劃(UnitedHealthcare Community and State)
聯合健康保險全球 (UnitedHealthcare Global)
卧騰 (Optum)
聯合健康集團為各種對象設計全系列的健保計劃與服務。聯合健康集團為全美九千萬人提供服務,約有30萬名僱員在全美50個州及130多個國家任職服務。
公司架構
聯合健康集團全球約有30萬名僱員以多單位的組織管理。
Optum
該品牌創立於2011,負責提供多元化醫療健康服務平台專注於新科技在健康照護領域的應用。
主要包括OptumHealth(健康管理公司)、OptumInsight(健康信息技術服務公司)和 OptumRx(藥品福利管理公司)。
UnitedHealthcare
UnitedHealthcare 包含四個主要事業體:
UnitedHealthcare Employer and Individual - 提供大型企業員工之健康保險計畫規劃服務。
UnitedHealthcare Medicare and Retirement - 提供65歲以上長者健康保險與退休福利計畫服務。
UnitedHealthcare Community and State - 提供州政府照顧計劃, 此種計劃以每月收取保費的形式,照顧經濟上處於不利地位,醫療狀況欠佳的人以及沒有雇主資助的醫療保險的人。
UnitedHealthcare Global - 提供醫療保險服務給130國的620萬民眾,主要包含巴西、智利、哥倫比亞與祕魯。
公司历史
2015年3月,联合健康旗下OptumRx宣布收购CatamaranRx。
2017年1月9日,UnitedHealth 的 Optum 宣布以23亿美金收购 Surgical Care Affiliates。
2017年,UnitedHealth的Optum部门收购了由Audax Health的高管创办的Rally Health。在被收购之前,UnitedHealth在2015年以大笔资金支持Rally Health,并通过在Rally Health的旗舰产品RallySM中招募500万UnitedHealth保单持有人。UnitedHealth,Audax Health和Rally Health之间的密切关系是Grant Vrestandig(Audax和Rally)与当时的UnitedHealth总裁兼首席财务官David Wichmann之间的密切个人关系。
2019年6月,UnitedHealth的Optum部门以43亿美元的价格从DaVita Inc.手中收购了Davita Medical Group。
2019年,联合健康公司同意以32亿美元的价格收购Equian。
2019年6月19日,UnitedHealth以未公开的价格收购了在线患者社区平台PatientLikeMe,并将其并入UnitedHealth Group的研究部门。
2024年12月4日,聯合健康保險行政總裁布莱恩·汤普森前往紐約參加年度投資者會議時遭一名男子開槍射殺。
== 参考资料及注释 ==
来源:维基百科, CC BY-SA 4.0 · 在维基百科上查看 ↗
UNH 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
UNH 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
10年表现 收入、净利润、利润率和每股收益趋势
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜?
盈利能力 毛利率、营业利润率和净利率;股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
财务健康 债务、流动性、偿付能力 — 资产负债表强度
成长 营收、每股收益 (EPS) 和净利润增长:同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
资本效率 资产周转率、库存周转率、应收账款周转率
股息 收益率、派息率、股息历史、5年CAGR
| 除息日 | 金额 |
|---|---|
| 2026年6月15日 | $2.3200 |
| 2026年3月9日 | $2.2100 |
| 2025年12月8日 | $2.2100 |
| 2025年9月15日 | $2.2100 |
| 2025年6月16日 | $2.2100 |
| 2025年3月10日 | $2.1000 |
| 2024年12月9日 | $2.1000 |
| 2024年9月16日 | $2.1000 |
| 2024年6月17日 | $2.1000 |
| 2024年3月8日 | $1.8800 |
| 2023年12月1日 | $1.8800 |
| 2023年9月8日 | $1.8800 |
| 2023年6月15日 | $1.8800 |
| 2023年3月10日 | $1.6500 |
| 2022年12月2日 | $1.6500 |
| 2022年9月9日 | $1.6500 |
| 2022年6月16日 | $1.6500 |
| 2022年3月11日 | $1.4500 |
| 2021年12月3日 | $1.4500 |
| 2021年9月10日 | $1.4500 |
UNH 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
- 强烈买入 8 23.5%
- 买入 19 55.9%
- 持有 7 20.6%
- 卖出 0 0.0%
- 强烈卖出 0 0.0%
12个月价格目标
26 位分析师 · 2026-08-22收益历史 每股收益实际值 vs 预估值,惊喜%,达标率,下次财报日期
| 期间 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|
| 2026年6月30日 | $6.38 | $4.95 | 1.4% |
| 2026年3月31日 | $7.23 | $6.64 | 0.59% |
| 2025年12月31日 | $2.11 | $2.12 | -0.01% |
| 2025年9月30日 | $2.92 | $2.82 | 0.10% |
| 2025年6月30日 | $4.08 | $4.53 | -0.45% |
| 2025年3月31日 | $7.20 | $7.36 | -0.16% |
同行比较(GICS 子行业) 关键指标与行业同行对比
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| UNH | $299.08B | 25.0 | 11.8% | 2.7% | 12.0% | — |
| ELV | $77.37B | 13.9 | 12.5% | 2.8% | 13.3% | — |
| HUM | $50.90B | 26.0 | 10.1% | 0.92% | 7.0% | — |
| CNC | $20.24B | -3.0 | 19.4% | -3.4% | -28.8% | 7.3% |
| MOH | $8.85B | 19.5 | 11.8% | 1.0% | 10.9% | — |
| HQY | $7.12B | 34.0 | 9.5% | 16.4% | 10.1% | 69.5% |
| ALHC | $4.03B | — | 46.1% | -0.02% | -0.52% | — |
| CLOV | — | -5.1 | 40.3% | -4.5% | -26.2% | — |
| PGNY | $2.14B | 39.5 | 10.4% | 4.5% | 11.3% | 23.6% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表 14
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $447.57B | $400.28B | $371.62B | $324.16B | $287.60B | $257.14B | $242.16B | $226.25B | $201.16B | $184.84B | $157.11B | $130.47B | |
| Cost of Revenue | $50.66B | $46.69B | $38.77B | $33.70B | $31.03B | $30.75B | $28.12B | $27.00B | $24.11B | $24.42B | $16.21B | $3.83B | |
| SG&A Expense | $59.59B | $53.01B | $54.63B | $47.78B | $42.58B | $41.70B | $35.19B | $34.07B | $29.56B | $28.40B | $24.31B | $21.26B | |
| Operating Expenses | $428.60B | $367.99B | $339.26B | $295.73B | $263.63B | $234.74B | $222.47B | $208.90B | $185.95B | $171.91B | $146.09B | $120.20B | |
| Operating Income | $18.96B | $32.29B | $32.36B | $28.43B | $23.97B | $22.41B | $19.68B | $17.34B | $15.21B | $12.93B | $11.02B | $10.27B | |
| Interest Expense | $4.00B | $3.91B | $3.25B | $2.09B | $1.66B | $1.66B | $1.70B | $1.40B | $1.19B | $1.07B | $790M | $618M | |
| Pretax Income | $14.70B | $20.07B | $29.11B | $26.34B | $22.31B | $20.74B | $17.98B | $15.94B | $14.02B | $11.86B | $10.23B | $9.66B | |
| Income Tax | $1.89B | $4.83B | $5.97B | $5.70B | $4.58B | $4.97B | $3.74B | $3.56B | $3.20B | $4.79B | $4.36B | $4.04B | |
| Net Income | $12.06B | $14.40B | $22.38B | $20.12B | $17.29B | $15.40B | $13.84B | $11.99B | $10.56B | $7.02B | $5.81B | $5.62B | |
| EPS (Basic) | $13.28 | $15.64 | $24.12 | $21.47 | $18.33 | $16.23 | $14.55 | $12.45 | $10.95 | $7.37 | $6.10 | $5.78 | |
| EPS (Diluted) | $13.23 | $15.51 | $23.86 | $21.18 | $18.08 | $16.03 | $14.33 | $12.19 | $10.72 | $7.25 | $6.01 | $5.70 | |
| Shares (Basic) | 908,000,000 | 921,000,000 | 928,000,000 | 937,000,000 | 943,000,000 | 949,000,000 | 951,000,000 | 963,000,000 | 964,000,000 | 952,000,000 | 953,000,000 | 972,000,000 | |
| Shares (Diluted) | 911,000,000 | 929,000,000 | 938,000,000 | 950,000,000 | 956,000,000 | 961,000,000 | 966,000,000 | 983,000,000 | 985,000,000 | 968,000,000 | 967,000,000 | 986,000,000 | |
| EBITDA | $18.96B | $32.29B | $32.36B | $28.43B | $23.97B | $22.41B | $19.68B | $17.34B | $15.21B | $12.93B | $11.02B | $10.27B |
资产负债表 26
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $24.36B | $25.31B | $25.43B | $23.36B | $21.38B | $16.92B | $10.98B | $10.87B | $11.98B | $10.43B | $10.92B | $7.50B | |
| Short-term Investments | $3.76B | $3.80B | $4.20B | $4.55B | $2.53B | $2.86B | $3.26B | $3.46B | $3.51B | $2.85B | $1.99B | $1.74B | |
| Receivables | $23.02B | $22.36B | $21.28B | $17.68B | $14.22B | $12.87B | $11.82B | $11.39B | $9.57B | $8.15B | $6.52B | $4.25B | |
| Inventory | $3.30B | $3.80B | $2.80B | $3.50B | $2.90B | · | · | · | · | · | · | · | |
| Prepaid Expense | $9.75B | $8.21B | $6.08B | $6.62B | $5.32B | $4.46B | $3.85B | $3.09B | $2.66B | $1.85B | $2.41B | $1.05B | |
| Current Assets | $90.58B | $85.78B | $78.44B | $69.07B | $61.76B | $53.72B | $42.63B | $38.69B | $37.08B | $33.88B | $31.64B | $23.56B | |
| PP&E (Net) | $10.76B | $10.55B | $11.45B | $10.13B | $8.97B | $8.63B | $8.70B | $8.46B | $7.01B | $5.90B | $4.86B | $4.42B | |
| Accum. Depreciation | $7.55B | $6.97B | $7.04B | $6.93B | $5.99B | $5.23B | $5.00B | $4.14B | $3.69B | $3.75B | $3.17B | $2.95B | |
| Goodwill | $110.50B | $106.73B | $103.73B | $93.35B | $75.80B | $71.34B | $65.66B | $58.91B | $54.56B | $47.58B | $44.45B | $32.94B | |
| Intangibles | $20.47B | $23.27B | $15.19B | $14.40B | $10.04B | $10.86B | $10.35B | $9.32B | $8.49B | $8.54B | $8.39B | $3.67B | |
| Other Non-current Assets | $23.01B | $19.59B | $17.30B | $15.03B | $12.53B | $11.51B | $9.33B | $4.33B | $3.58B | $3.04B | $3.12B | $2.97B | |
| Total Assets | $309.58B | $298.28B | $273.72B | $245.71B | $212.21B | $197.29B | $173.89B | $152.22B | $139.06B | $122.81B | $111.25B | $86.30B | |
| Accounts Payable | $38.03B | $34.34B | $31.96B | $27.71B | $24.64B | $22.50B | $19.00B | $16.70B | $15.18B | $13.36B | $11.99B | $9.25B | |
| Current Liabilities | $114.90B | $103.77B | $99.05B | $89.24B | $78.29B | $72.42B | $61.78B | $53.21B | $50.46B | $49.25B | $42.90B | $30.62B | |
| Deferred Tax | $2.42B | $3.62B | $3.02B | $2.77B | $3.27B | $3.37B | $2.99B | $2.47B | $2.18B | $2.76B | $3.59B | $2.06B | |
| Other Non-current Liabilities | $18.25B | $15.94B | $14.46B | $12.84B | $11.79B | $12.31B | $10.14B | $5.73B | $5.56B | $4.83B | $1.48B | $1.36B | |
| Total Liabilities | $207.88B | $195.69B | $174.80B | $159.36B | $135.73B | $126.75B | $111.73B | $95.99B | $87.04B | $82.62B | $75.79B | $52.54B | |
| Long-term Debt | · | · | · | · | $46.00B | $43.47B | $40.68B | $36.55B | $31.69B | $32.97B | $31.96B | $17.41B | |
| Total Debt | $72.32B | $72.36B | $58.26B | $54.51B | $46.00B | $43.47B | $40.68B | $36.55B | $31.69B | $32.97B | $32.09B | $17.41B | |
| Common Stock | $9M | $9M | $9M | $9M | $10M | $10M | $9M | $10M | $10M | $10M | $10M | $10M | |
| Paid-in Capital | $559M | $0 | $0 | · | $0 | $0 | $7M | $0 | $1.70B | $0 | $29M | $0 | |
| Retained Earnings | $95.60B | $96.04B | $95.77B | $86.16B | $77.13B | $69.30B | $61.18B | $55.85B | $48.73B | $40.95B | $37.12B | $33.84B | |
| AOCI | $-2.06B | $-3.39B | $-7.03B | $-8.39B | $-5.38B | $-3.81B | $-3.58B | $-4.16B | $-2.67B | $-2.68B | $-3.33B | $-1.39B | |
| Stockholders' Equity | $100.09B | $98.27B | $94.42B | $81.45B | $75.05B | $68.33B | $60.44B | $54.32B | $49.83B | $38.18B | $33.73B | $32.45B | |
| Liabilities + Equity | $309.58B | $298.28B | $273.72B | $245.71B | $212.21B | $197.29B | $173.89B | $152.22B | $139.06B | $122.81B | $111.25B | $86.38B | |
| Shares Outstanding | 906,000,000 | 915,000,000 | 924,000,000 | 934,000,000 | 941,000,000 | 946,000,000 | 948,000,000 | 960,000,000 | 969,000,000 | 952,000,000 | 953,000,000 | 954,000,000 |
现金流 18
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4.36B | $4.10B | $3.97B | $3.40B | $3.10B | $2.89B | $2.72B | $2.43B | $2.25B | $2.06B | $1.69B | $1.48B | |
| Stock-based Comp | $971M | $1.02B | $1.06B | $925M | $800M | $679M | $697M | $638M | $597M | $485M | $406M | $364M | |
| Deferred Tax | $-1.75B | $-296M | $-245M | $-673M | $130M | $-8M | $230M | $42M | $-965M | $81M | $-73M | $-117M | |
| Amort. of Intangibles | $1.70B | $1.70B | $1.60B | $1.30B | $1.20B | $1.10B | $1.00B | $898M | $896M | $882M | $650M | $524M | |
| Operating Cash Flow | $19.70B | $24.20B | $29.07B | $26.21B | $22.34B | $22.17B | $18.46B | $15.71B | $13.60B | $9.79B | $9.74B | $8.05B | |
| CapEx | $3.62B | $3.50B | $3.39B | $2.80B | $2.45B | $2.05B | $2.07B | $2.06B | $2.02B | $1.71B | $1.56B | $1.52B | |
| Investing Cash Flow | $-8.69B | $-20.53B | $-15.57B | $-28.48B | $-10.37B | $-12.53B | $-12.70B | $-12.38B | $-8.60B | $-9.36B | $-18.39B | $-2.53B | |
| Debt Issued | $2.97B | $17.81B | $6.39B | $14.82B | $6.93B | $4.86B | $5.44B | $6.93B | $5.29B | $3.97B | $11.98B | $2.00B | |
| Net Debt Issued | $-81M | $14.81B | $4.27B | $11.80B | $3.78B | $1.71B | $3.69B | $4.33B | $893M | $1.37B | $10.94B | $1.19B | |
| Stock Issued | $827M | $1.85B | $1.35B | $1.25B | $1.35B | $1.44B | $1.04B | $838M | $688M | $429M | $402M | $462M | |
| Stock Repurchased | $5.54B | $9.00B | $8.00B | $7.00B | $5.00B | $4.25B | $5.50B | $4.50B | $1.50B | $1.28B | $1.20B | $4.01B | |
| Net Stock Activity | $-4.72B | $-7.15B | $-6.65B | $-5.75B | $-3.65B | $-2.81B | $-4.46B | $-3.66B | $-812M | $-851M | $-798M | $-3.55B | |
| Dividends Paid | $7.92B | $7.53B | $6.76B | $5.99B | $5.28B | $4.58B | $3.93B | $3.32B | $2.77B | $2.26B | $1.79B | $1.36B | |
| Financing Cash Flow | $-11.64B | $-3.51B | $-11.53B | $4.23B | $-7.46B | $-3.59B | $-5.62B | $-4.37B | $-3.44B | $-1.01B | $12.24B | $-5.29B | |
| Net Change in Cash | $-947M | $-115M | $2.06B | $1.99B | $4.45B | $5.94B | $119M | $-1.11B | $1.55B | $-493M | $3.43B | $219M | |
| Taxes Paid | $3.71B | $4.62B | $6.08B | $5.22B | $3.97B | $4.93B | $3.54B | $3.26B | $4.00B | $4.73B | $4.40B | $4.02B | |
| Free Cash Flow | $16.07B | $20.70B | $25.68B | $23.40B | $19.89B | $20.12B | $16.39B | $13.65B | $11.57B | $8.09B | $8.18B | $6.53B | |
| Levered FCF | $12.59B | $17.74B | $23.10B | $21.76B | $18.57B | $18.86B | $15.04B | $12.56B | $10.66B | $7.45B | $7.73B | $6.17B |
盈利能力 7
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 4.2% | 8.1% | 8.7% | 8.8% | 8.3% | 8.7% | 8.1% | 7.7% | 7.6% | 7.0% | 7.0% | 7.9% | |
| Net Margin | 2.7% | 3.6% | 6.0% | 6.2% | 6.0% | 6.0% | 5.7% | 5.3% | 5.2% | 3.8% | 3.7% | 4.3% | |
| Pretax Margin | 3.3% | 5.0% | 7.8% | 8.1% | 7.8% | 8.1% | 7.4% | 7.0% | 7.0% | 6.4% | 6.5% | 7.4% | |
| EBITDA Margin | 4.2% | 8.1% | 8.7% | 8.8% | 8.3% | 8.7% | 8.1% | 7.7% | 7.6% | 7.0% | 7.0% | 7.9% | |
| ROA | 4.0% | 4.8% | 8.6% | 8.8% | 8.4% | 8.3% | 8.5% | 8.2% | 8.1% | 6.0% | 5.9% | 6.7% | |
| ROE | 12.0% | 14.5% | 24.3% | 25.2% | 23.3% | 22.6% | 23.4% | 22.4% | 21.7% | 18.5% | 17.4% | 17.3% | |
| ROIC | 9.6% | 14.4% | 16.9% | 16.4% | 15.7% | 15.2% | 15.4% | 14.8% | 14.4% | 10.8% | 9.6% | 12.0% |
流动性与偿付能力 5
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 0.8 | 0.8 | 0.8 | 0.8 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.8 | |
| Quick Ratio | 0.4 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.4 | 0.5 | 0.5 | 0.4 | 0.5 | 0.4 | |
| Debt / Equity | 0.7 | 0.7 | 0.6 | 0.7 | 0.6 | 0.6 | 0.7 | 0.7 | 0.6 | 0.9 | 1.0 | 0.5 | |
| LT Debt / Equity | 0.7 | 0.7 | 0.6 | 0.7 | 0.6 | 0.6 | 0.6 | 0.6 | 0.6 | 0.7 | 0.8 | 0.5 | |
| Interest Coverage | 4.7 | 8.3 | 10.0 | 13.6 | 14.4 | 13.5 | 11.6 | 12.4 | 12.8 | 12.1 | 14.0 | 16.6 |
效率 3
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 1.5 | 1.3 | 1.4 | 1.4 | 1.4 | 1.4 | 1.5 | 1.6 | 1.5 | 1.6 | 1.6 | 1.6 | |
| Inventory Turnover | 14.3 | 14.1 | 12.3 | 10.5 | · | · | · | · | · | · | · | · | |
| Receivables Turnover | 19.7 | 18.3 | 19.1 | 20.3 | 21.2 | 20.8 | 20.9 | 21.6 | 22.7 | 25.2 | 29.2 | 35.7 |
增长率 10
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 11.8% | 7.7% | 14.6% | 12.7% | 11.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 11.3% | 11.7% | 13.1% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.7% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -14.7% | -35.0% | 12.7% | 17.2% | 12.8% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | -14.5% | -5.0% | 14.2% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | -3.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -16.3% | -35.6% | 11.2% | 16.4% | 12.2% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -15.7% | -5.9% | 13.3% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -4.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividend CAGR 5Y | 11.6% | · | · | · | · | · | · | · | · | · | · | · |
估值 (TTM) 16
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $447.57B | $400.28B | $371.62B | $324.16B | $287.60B | $257.14B | $242.16B | $226.25B | $201.16B | $184.84B | $157.11B | $130.47B | |
| Net Income TTM | $12.06B | $14.40B | $22.38B | $20.12B | $17.29B | $15.40B | $13.84B | $11.99B | $10.56B | $7.02B | $5.81B | $5.62B | |
| Market Cap | $299.08B | $462.86B | $486.46B | $495.19B | $472.51B | $331.74B | $278.69B | $239.16B | $213.63B | $152.36B | $112.11B | $96.44B | |
| Enterprise Value | $343.28B | $506.11B | $515.09B | $521.79B | $494.61B | $355.43B | $305.13B | $261.39B | $229.83B | $172.05B | $131.29B | $104.61B | |
| P/E | 25.0 | 32.6 | 22.1 | 25.0 | 27.8 | 21.9 | 20.5 | 20.4 | 20.6 | 22.1 | 19.6 | 17.7 | |
| P/S | 0.7 | 1.2 | 1.3 | 1.5 | 1.6 | 1.3 | 1.2 | 1.1 | 1.1 | 0.8 | 0.7 | 0.7 | |
| P/B | 3.0 | 4.7 | 5.2 | 6.1 | 6.3 | 4.9 | 4.6 | 4.4 | 4.3 | 4.0 | 3.3 | 3.0 | |
| P / Cash Flow | 15.2 | 19.1 | 16.7 | 18.9 | 21.1 | 15.0 | 15.1 | 15.2 | 15.7 | 15.6 | 11.5 | 12.0 | |
| P / FCF | 18.6 | 22.4 | 18.9 | 21.2 | 23.8 | 16.5 | 17.0 | 17.5 | 18.5 | 18.8 | 13.7 | 14.8 | |
| EV / EBITDA | 18.1 | 15.7 | 15.9 | 18.4 | 20.6 | 15.9 | 15.5 | 15.1 | 15.1 | 13.3 | 11.9 | 10.2 | |
| EV / FCF | 21.4 | 24.4 | 20.1 | 22.3 | 24.9 | 17.7 | 18.6 | 19.1 | 19.9 | 21.3 | 16.0 | 16.0 | |
| EV / Revenue | 0.8 | 1.3 | 1.4 | 1.6 | 1.7 | 1.4 | 1.3 | 1.2 | 1.1 | 0.9 | 0.8 | 0.8 | |
| Dividend Yield | 2.6% | 1.6% | 1.4% | 1.2% | 1.1% | 1.4% | 1.4% | 1.4% | 1.3% | 1.5% | 1.6% | 1.4% | |
| Earnings Yield | 4.0% | 3.1% | 4.5% | 4.0% | 3.6% | 4.6% | 4.9% | 4.9% | 4.9% | 4.5% | 5.1% | 5.6% | |
| Payout Ratio | 65.7% | 52.3% | 30.2% | 29.8% | 30.6% | 29.8% | 28.4% | 27.7% | 26.3% | 32.2% | 30.7% | 24.2% | |
| Annual Payout | $7.92B | $7.53B | $6.76B | $5.99B | $5.28B | $4.58B | $3.93B | $3.32B | $2.77B | $2.26B | $1.79B | $1.36B |
损益表 14
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $112.03B | $111.72B | $113.22B | $113.16B | $111.62B | $109.58B | $100.81B | $100.82B | $98.86B | $99.80B | $94.43B | $92.36B | $92.90B | $91.93B | $82.79B | $80.89B | |
| Cost of Revenue | $13.38B | $12.82B | $12.68B | $12.57B | $13.02B | $12.39B | $12.46B | $11.83B | $11.34B | $11.06B | $10.19B | $9.42B | $9.75B | $9.40B | $8.31B | $8.31B | |
| SG&A Expense | $14.27B | $15.39B | $17.00B | $15.22B | $13.78B | $13.59B | $12.49B | $13.28B | $13.16B | $14.08B | $13.34B | $13.86B | $13.81B | $13.62B | $13.01B | $11.66B | |
| Operating Expenses | $104.04B | $102.73B | $112.83B | $108.85B | $106.47B | $100.46B | $93.03B | $92.11B | $90.98B | $91.86B | $86.74B | $83.83B | $84.85B | $83.84B | $75.90B | $73.43B | |
| Operating Income | $7.99B | $8.99B | $380M | $4.32B | $5.15B | $9.12B | $7.77B | $8.71B | $7.88B | $7.93B | $7.69B | $8.53B | $8.06B | $8.09B | $6.89B | $7.46B | |
| Interest Expense | $962M | $955M | $974M | $1.00B | $1.03B | $998M | $1.00B | $1.07B | $985M | $844M | $830M | $834M | $828M | $754M | $676M | $516M | |
| Pretax Income | $6.97B | $7.96B | $-720M | $3.23B | $4.08B | $8.11B | $6.79B | $7.61B | $5.67B | $1M | $6.86B | $7.69B | $7.23B | $7.33B | $6.21B | $6.95B | |
| Income Tax | $1.30B | $1.48B | $-938M | $686M | $510M | $1.63B | $1.01B | $1.36B | $1.24B | $1.22B | $1.18B | $1.65B | $1.57B | $1.56B | $1.31B | $1.56B | |
| Net Income | $5.48B | $6.28B | $10M | $2.35B | $3.41B | $6.29B | $5.54B | $6.05B | $4.22B | $-1.41B | $5.46B | $5.84B | $5.47B | $5.61B | $4.76B | $5.26B | |
| EPS (Basic) | $6.06 | $6.92 | $0.03 | $2.59 | $3.76 | $6.90 | $6.03 | $6.56 | $4.58 | $-1.53 | $5.91 | $6.31 | $5.89 | $6.01 | $5.09 | $5.63 | |
| EPS (Diluted) | $6.04 | $6.90 | $0.05 | $2.59 | $3.74 | $6.85 | $5.99 | $6.51 | $4.54 | $-1.53 | $5.85 | $6.24 | $5.82 | $5.95 | $5.02 | $5.55 | |
| Shares (Basic) | 902,000,000 | 908,000,000 | -1,817,000,000 | 906,000,000 | 907,000,000 | 912,000,000 | -1,845,000,000 | 923,000,000 | 921,000,000 | 922,000,000 | -1,861,000,000 | 926,000,000 | 930,000,000 | 933,000,000 | -1,876,000,000 | 935,000,000 | |
| Shares (Diluted) | 906,000,000 | 910,000,000 | -1,825,000,000 | 908,000,000 | 910,000,000 | 918,000,000 | -1,851,000,000 | 930,000,000 | 928,000,000 | 922,000,000 | -1,881,000,000 | 936,000,000 | 940,000,000 | 943,000,000 | -1,902,000,000 | 948,000,000 | |
| EBITDA | $7.99B | $8.99B | · | $4.32B | $5.15B | $9.12B | · | $8.71B | $7.88B | $7.93B | · | $8.53B | $8.06B | $8.09B | · | $7.46B |
资产负债表 26
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $28.59B | $28.00B | $24.36B | $27.21B | $28.60B | $30.72B | $25.31B | $32.40B | $26.29B | $28.41B | · | $38.91B | $41.81B | $41.91B | · | $38.84B | |
| Short-term Investments | $2.88B | $3.23B | $3.76B | $3.40B | $3.42B | $3.57B | $3.80B | $4.73B | $5.04B | $4.30B | · | $5.18B | $4.47B | $4.58B | · | $3.68B | |
| Receivables | $21.57B | $26.59B | $23.02B | $22.67B | $24.14B | $26.94B | $22.36B | $20.02B | $23.11B | $27.20B | · | $20.67B | $17.95B | $22.41B | · | $17.05B | |
| Inventory | · | · | $3.30B | · | · | · | $3.80B | · | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $9.10B | $8.72B | $9.75B | $9.02B | $8.96B | $9.04B | $8.21B | $7.64B | $7.42B | $6.13B | · | $5.77B | $5.88B | $6.45B | · | $5.66B | |
| Current Assets | $86.86B | $91.13B | $90.58B | $95.07B | $93.70B | $96.28B | $85.78B | $92.26B | $92.04B | $88.94B | · | $91.91B | $89.87B | $93.89B | · | $82.94B | |
| PP&E (Net) | $10.76B | $10.67B | $10.76B | $11.10B | $10.92B | $10.73B | $10.55B | $10.14B | $9.80B | $10.43B | · | $11.07B | $10.93B | $10.64B | · | $9.47B | |
| Accum. Depreciation | · | · | $7.55B | · | · | · | $6.97B | · | · | · | · | · | · | · | · | · | |
| Goodwill | $110.64B | $110.51B | $110.50B | $110.34B | $107.68B | $107.57B | $106.73B | $105.98B | $105.44B | $105.66B | $103.73B | $101.70B | $101.67B | $100.41B | $93.35B | $83.90B | |
| Intangibles | $19.75B | $20.09B | $20.47B | $22.79B | $22.51B | $22.95B | $23.27B | $23.59B | $14.73B | $15.54B | · | $15.20B | $15.64B | $16.16B | · | $10.79B | |
| Other Non-current Assets | $24.00B | $23.46B | $23.01B | $22.98B | $21.30B | $20.39B | $19.59B | $18.65B | $17.94B | $17.70B | · | $16.71B | $16.07B | $15.69B | · | $14.41B | |
| Total Assets | $309.73B | $312.64B | $309.58B | $315.27B | $308.57B | $309.79B | $298.28B | $299.31B | $286.06B | $284.21B | $273.72B | $282.06B | $280.16B | $283.68B | $245.71B | $243.06B | |
| Accounts Payable | $39.74B | $38.63B | $38.03B | $36.03B | $34.33B | $33.57B | $34.34B | $33.08B | $30.89B | $30.74B | · | $31.16B | $29.52B | $29.86B | · | $27.23B | |
| Short-term Debt | · | · | · | · | · | · | · | · | · | $7.30B | · | $2.60B | $4.40B | $8.20B | · | · | |
| Current Liabilities | $111.82B | $114.12B | $114.90B | $115.53B | $110.78B | $113.47B | $103.77B | $101.56B | $104.67B | $104.43B | · | $114.18B | $112.98B | $116.48B | · | $100.94B | |
| Deferred Tax | $2.72B | $2.86B | $2.42B | $3.16B | $3.80B | $3.90B | $3.62B | $4.01B | $3.63B | $4.17B | · | $2.21B | $2.50B | $2.83B | · | $1.66B | |
| Other Non-current Liabilities | $19.73B | $18.90B | $18.25B | $18.37B | $15.71B | $15.96B | $15.94B | $15.17B | $14.79B | $14.84B | · | $13.62B | $13.26B | $13.08B | · | $12.11B | |
| Total Liabilities | $203.78B | $207.32B | $207.88B | $209.46B | $203.79B | $204.62B | $195.69B | $194.85B | $186.82B | $187.29B | · | $188.08B | $188.01B | $193.06B | · | $160.14B | |
| Total Debt | $69.50B | $71.44B | · | $72.40B | $73.50B | $71.28B | · | $74.10B | $63.73B | $71.15B | · | $60.68B | $63.67B | $68.86B | · | $45.44B | |
| Common Stock | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | $9M | · | $9M | $9M | $9M | · | $10M | |
| Paid-in Capital | $0 | $556M | $559M | $394M | · | · | $0 | $461M | $373M | · | · | · | · | · | · | · | |
| Retained Earnings | $100.96B | $99.88B | $95.60B | $97.59B | $97.25B | $97.93B | $96.04B | $96.52B | $92.40B | $90.12B | · | $93.17B | $89.99B | $88.85B | · | $83.72B | |
| AOCI | $-2.52B | $-2.56B | $-2.06B | $-2.21B | $-2.54B | $-2.90B | $-3.39B | $-2.45B | $-3.42B | $-3.44B | · | $-8.69B | $-7.65B | $-7.55B | · | $-9.09B | |
| Stockholders' Equity | $104.51B | $103.89B | $100.09B | $101.57B | $100.47B | $100.81B | $98.27B | $99.88B | $94.68B | $92.37B | $94.42B | $89.56B | $87.37B | $85.82B | $81.45B | $78.06B | |
| Liabilities + Equity | $309.73B | $312.64B | $309.58B | $315.27B | $308.57B | $309.79B | $298.28B | $299.31B | $286.06B | $284.21B | · | $282.06B | $280.16B | $283.68B | · | $243.06B | |
| Shares Outstanding | 905,000,000 | 908,000,000 | 906,000,000 | 906,000,000 | 905,000,000 | 910,000,000 | 915,000,000 | 923,000,000 | 921,000,000 | 920,000,000 | 924,000,000 | 925,000,000 | 927,000,000 | 932,000,000 | 934,000,000 | 935,000,000 |
现金流 16
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $1.04B | $1.03B | $1.12B | $1.10B | $1.08B | $1.06B | $1.04B | $1.04B | $1.02B | $997M | $974M | $1.01B | $1.02B | $970M | $982M | $828M | |
| Stock-based Comp | $276M | $348M | $176M | $223M | $197M | $375M | $187M | $237M | $222M | $372M | $208M | $247M | $242M | $362M | $250M | $171M | |
| Deferred Tax | $-129M | $540M | $-733M | $-932M | $-151M | $64M | $-62M | $124M | $-331M | $-27M | $249M | $-12M | $-150M | $-332M | $-83M | $-575M | |
| Operating Cash Flow | $11.05B | $8.91B | $1.11B | $5.95B | $7.19B | $5.46B | $2.37B | $13.95B | $6.75B | $1.14B | $-5.19B | $6.90B | $11.03B | $16.33B | $-4.53B | $18.55B | |
| CapEx | $799M | $763M | $948M | $890M | $886M | $898M | $912M | $991M | $853M | $743M | $959M | $838M | $829M | $760M | $866M | $724M | |
| Investing Cash Flow | $-1.80B | $-2.45B | $-2.61B | $-4.56B | $-1.44B | $-74M | $-1.12B | $-5.65B | $-7.42B | $-6.34B | $-1.19B | $-2.64B | $-728M | $-11.02B | $-15.37B | $-847M | |
| Debt Issued | · | · | $0 | $0 | $2.97B | $0 | $0 | $11.89B | $0 | $5.92B | $0 | $0 | $-7M | $6.40B | $8.90B | $0 | |
| Net Debt Issued | · | $-1.50B | · | · | · | $0 | · | · | · | $5.17B | · | · | · | $5.03B | · | · | |
| Stock Issued | $128M | $231M | $24M | $222M | $221M | $360M | $235M | $867M | $258M | $486M | $314M | $411M | $284M | $344M | $169M | $328M | |
| Stock Repurchased | $1.65B | $0 | $0 | $0 | $2.54B | $3.00B | $4.97B | $956M | $0 | $3.07B | $1.50B | $1.50B | $3.00B | $2.00B | $1.00B | $1.00B | |
| Net Stock Activity | · | $231M | · | · | · | $-2.64B | · | · | · | $-2.59B | · | · | · | $-1.66B | · | · | |
| Dividends Paid | $2.09B | $2.00B | $2.00B | $2.00B | $2.00B | $1.91B | $1.93B | $1.94B | $1.94B | $1.73B | $1.74B | $1.74B | $1.75B | $1.54B | $1.54B | $1.54B | |
| Financing Cash Flow | $-8.62B | $-2.99B | $-1.03B | $-2.77B | $-7.95B | $99M | $-8.34B | $-2.21B | $-1.20B | $8.23B | $-7.16B | $-7.10B | $-10.46B | $13.19B | $4.39B | $-3.42B | |
| Net Change in Cash | $584M | $3.64B | $-2.85B | $-1.39B | $-2.12B | $5.41B | $-7.09B | $6.11B | $-2.13B | $2.99B | $-13.49B | $-2.90B | $-100M | $18.55B | $-15.48B | $14.23B | |
| Free Cash Flow | · | $8.15B | · | · | · | $4.56B | · | · | · | $401M | · | · | · | $15.57B | · | · | |
| Levered FCF | · | $7.37B | · | · | · | $3.76B | · | · | · | $1.03T | · | · | · | $14.97B | · | · |
盈利能力 7
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 7.1% | 8.1% | · | 3.8% | 4.6% | 8.3% | · | 8.6% | 8.0% | 8.0% | · | 9.2% | 8.7% | 8.8% | · | 9.2% | |
| Net Margin | 4.9% | 5.6% | · | 2.1% | 3.0% | 5.7% | · | 6.0% | 4.3% | -1.4% | · | 6.3% | 5.9% | 6.1% | · | 6.5% | |
| Pretax Margin | 6.2% | 7.1% | · | 2.9% | 3.7% | 7.4% | · | 7.5% | 5.7% | 0.00% | · | 8.3% | 7.8% | 8.0% | · | 8.6% | |
| EBITDA Margin | 7.1% | 8.1% | · | 3.8% | 4.6% | 8.3% | · | 8.6% | 8.0% | 8.0% | · | 9.2% | 8.7% | 8.8% | · | 9.2% | |
| ROA | 1.8% | 2.0% | · | 0.76% | 1.1% | 2.1% | · | 2.1% | 1.5% | -0.50% | · | 2.2% | 2.1% | 2.2% | · | 2.3% | |
| ROE | 5.3% | 6.1% | · | 2.3% | 3.5% | 6.5% | · | 6.4% | 4.6% | -1.6% | · | 7.0% | 6.7% | 6.9% | · | 7.0% | |
| ROIC | 3.7% | 4.2% | · | 1.9% | 2.6% | 4.2% | · | 4.1% | 3.9% | -5922.1% | · | 4.5% | 4.2% | 4.1% | · | 4.7% |
流动性与偿付能力 5
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.8 | 0.8 | · | 0.8 | 0.8 | 0.8 | · | 0.9 | 0.9 | 0.9 | · | 0.8 | 0.8 | 0.8 | · | 0.8 | |
| Quick Ratio | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.5 | · | 0.6 | 0.5 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | |
| Debt / Equity | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.8 | · | 0.7 | 0.7 | 0.8 | · | 0.6 | |
| LT Debt / Equity | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.7 | 0.7 | 0.7 | · | 0.6 | 0.7 | 0.7 | · | 0.6 | |
| Interest Coverage | 8.3 | 9.4 | · | 4.3 | 5.0 | 9.1 | · | 8.1 | 8.0 | 9.4 | · | 10.2 | 9.7 | 10.7 | · | 14.5 |
效率 2
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.3 | 0.3 | 0.4 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | |
| Receivables Turnover | 4.9 | 4.2 | · | 5.3 | 4.7 | 4.0 | · | 5.0 | 4.8 | 4.0 | · | 4.9 | 5.1 | 4.5 | · | 5.2 |
估值 (TTM) 14
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $448.53B | $446.07B | · | $435.17B | $420.87B | $409.05B | · | $391.83B | $383.92B | $376.99B | · | $358.09B | $346.06B | $333.31B | · | $313.71B | |
| Net Income TTM | $17.52B | $18.33B | · | $18.10B | $19.97B | $15.15B | · | $14.70B | $14.12B | $15.52B | · | $22.19B | $21.42B | $20.97B | · | $19.45B | |
| Market Cap | $376.15B | $245.70B | · | $312.84B | $282.33B | $476.61B | · | $539.66B | $469.03B | $455.12B | · | $466.38B | $445.55B | $440.45B | · | $472.21B | |
| Enterprise Value | $414.18B | $285.91B | · | $354.63B | $323.81B | $513.61B | · | $576.63B | $501.43B | $493.56B | · | $482.96B | $462.94B | $462.81B | · | $475.12B | |
| P/E | 21.6 | 13.5 | · | 17.5 | 14.4 | 32.0 | · | 37.1 | 33.8 | 30.0 | · | 21.4 | 21.2 | 21.4 | · | 24.7 | |
| P/S | 0.8 | 0.6 | · | 0.7 | 0.7 | 1.2 | · | 1.4 | 1.2 | 1.2 | · | 1.3 | 1.3 | 1.3 | · | 1.5 | |
| P/B | 3.6 | 2.4 | · | 3.1 | 2.8 | 4.7 | · | 5.4 | 5.0 | 4.9 | · | 5.2 | 5.1 | 5.1 | · | 6.0 | |
| P / Cash Flow | · | 27.6 | · | · | · | 87.4 | · | · | · | 397.8 | · | · | · | 27.0 | · | · | |
| P / FCF | · | 30.2 | · | · | · | 104.6 | · | · | · | 1135.0 | · | · | · | 28.3 | · | · | |
| EV / EBITDA | 51.8 | 31.8 | · | 82.2 | 62.9 | 56.3 | · | 66.2 | 63.7 | 62.2 | · | 56.6 | 57.5 | 57.2 | · | 63.7 | |
| EV / FCF | · | 35.1 | · | · | · | 112.7 | · | · | · | 1230.8 | · | · | · | 29.7 | · | · | |
| EV / Revenue | 0.9 | 0.6 | · | 0.8 | 0.8 | 1.3 | · | 1.5 | 1.3 | 1.3 | · | 1.3 | 1.3 | 1.4 | · | 1.5 | |
| Earnings Yield | 4.6% | 7.4% | · | 5.7% | 6.9% | 3.1% | · | 2.7% | 3.0% | 3.3% | · | 4.7% | 4.7% | 4.7% | · | 4.0% | |
| Payout Ratio | · | 31.9% | · | · | · | 30.4% | · | · | · | -122.7% | · | · | · | 27.4% | · | · |
财务报表 损益表、资产负债表、现金流量表 — 年度,近5年
损益表
| 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 收入 | $447.57B | — | — | $400.28B | — |
| 营业利润率 % | 4.2% | — | — | 8.1% | — |
| 净收入 | $12.06B | — | — | $14.40B | — |
| 稀释后每股收益 (EPS) | $13.23 | — | — | $15.51 | — |
资产负债表
| 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 负债/股东权益比率 | 0.7 | — | — | 0.7 | — |
| 流动比率 | 0.8 | — | — | 0.8 | — |
| 速动比率 | 0.4 | — | — | 0.5 | — |
现金流
| 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | |
|---|---|---|---|---|---|
| 自由现金流 | $16.07B | — | — | $20.70B | — |
最新新闻 提及该公司的近期头条新闻
- 联合健康股价是否仍被低估?
- UnitedHealth Lost Nearly 1 Million Medicare Members. Here's Why Investors Aren't Worried
- UnitedHealth Group boosts earnings outlook after stronger-than-expected Q2 results
- 最新财报发布后,联合健康集团 (UNH) 是否值得买入?
- JPMorgan Raises its Price Target on UnitedHealth Group (UNH)
- UnitedHealth Stock Jumps on Upgrade From Bank of America. UNH Is No Longer Just an Insurance Company.
- 每日股息报告:MDT,ACM,UNH,RICK,VRT
- 这家医疗保健巨头正悄然成为人工智能的领军者
- UnitedHealth Group (UNH) – 华尔街对冲基金看好的10只优质股票之一
- 联合健康 (UNH) 股价在伯克希尔·哈撒韦退出后下跌,路透社报道
交易信号 近期买入/卖出信号,包含入场价和风险/回报比
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 ➕。
您的选择已保存,并会跟随您浏览所有股票。
机构持有人 (13F) 3750 家申报者 · $243.6B 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸;单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存,而非方向性判断。
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 507 (+257 与上一季度对比) | 124 (-254 与上一季度对比) | 1283 (+66 与上一季度对比) | 1289 (-96 与上一季度对比) | +25.6M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天,外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过,优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| VANGUARD GROUP INC | $27207979474 | 82420949 | 11.17% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $24651649136 | 59311525 | 10.12% | 股份 |
| STATE STREET CORP | $18966554763 | 45633267 | 7.79% | 股份 |
| Capital World Investors | $12422776956 | 29887932 | 5.10% | 股份 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $10175966547 | 24483234 | 4.18% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $7770611877 | 18774463 | 3.19% | 股份 |
| FMR LLC | $7185101298 | 17287254 | 2.95% | 股份 |
| NORGES BANK | $5293868088 | 12736973 | 2.17% | 股份 |
| Capital Research Global Investors | $4378631657 | 10534177 | 1.80% | 股份 |
| WELLINGTON MANAGEMENT GROUP LLP | $4210086678 | 10129410 | 1.73% | 股份 |
| Fisher Asset Management, LLC | $3774863715 | 9082269 | 1.55% | 股份 |
| Dodge & Cox | $3770702593 | 9072258 | 1.55% | 股份 |
| Capital International Investors | $3237872783 | 7789028 | 1.33% | 股份 |
| JANE STREET GROUP, LLC | $3165978399 | 7617300 | 1.30% | 买入期权 |
| Sanders Capital, LLC | $2451649249 | 5898634 | 1.01% | 股份 |
| EAGLE CAPITAL MANAGEMENT LLC | $2399442912 | 5773026 | 0.99% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $2119167278 | 5098687 | 0.87% | 股份 |
| ALLIANCEBERNSTEIN L.P. | $2075268358 | 7669420 | 0.85% | 股份 |
| MORGAN STANLEY | $2055731816 | 4946062 | 0.84% | 股份 |
| JANE STREET GROUP, LLC | $2055124098 | 4944600 | 0.84% | 卖出期权 |
| DIMENSIONAL FUND ADVISORS LP | $1717292161 | 4131778 | 0.71% | 股份 |
| BNP PARIBAS FINANCIAL MARKETS | $1526781892 | 3673416 | 0.63% | 股份 |
| AMERIPRISE FINANCIAL INC | $1405176851 | 3380319 | 0.58% | 股份 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $1251138985 | 3010223 | 0.51% | 股份 |
| Grantham, Mayo, Van Otterloo & Co. LLC | $1174164878 | 2825022 | 0.48% | 股份 |
| BlackRock, Inc. | $1158005862 | 2786146 | 0.48% | 股份 |
| UBS Group AG | $1092471817 | 2628472 | 0.45% | 买入期权 |
| BANK OF AMERICA CORP /DE/ | $1087853337 | 2617360 | 0.45% | 股份 |
| Mitsubishi UFJ Asset Management Co., Ltd. | $1065664884 | 2563973 | 0.44% | 股份 |
| Swiss National Bank | $1064029841 | 2560041 | 0.44% | 股份 |
| Sumitomo Mitsui Trust Group, Inc. | $1055107927 | 2538575 | 0.43% | 股份 |
| CANADA PENSION PLAN INVESTMENT BOARD | $971757071 | 2338034 | 0.40% | 股份 |
| BARCLAYS PLC | $897842266 | 2160196 | 0.37% | 股份 |
| RAYMOND JAMES FINANCIAL INC | $874984816 | 2105201 | 0.36% | 股份 |
| Walleye Trading LLC | $861060671 | 2071700 | 0.35% | 卖出期权 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $860919095 | 2071359 | 0.35% | 股份 |
| VANGUARD ASSET MANAGEMENT, Ltd | $847773811 | 2039732 | 0.35% | 股份 |
| Walleye Trading LLC | $845183605 | 2033500 | 0.35% | 买入期权 |
| Vanguard Global Advisers, LLC | $819257021 | 1971121 | 0.34% | 股份 |
| National Pension Service | $818929089 | 1970332 | 0.34% | 股份 |
| WOLVERINE TRADING, LLC | $815453232 | 2362400 | 0.33% | 买入期权 |
| ENVESTNET ASSET MANAGEMENT INC | $811129699 | 1951573 | 0.33% | 股份 |
| California Public Employees Retirement System | $799750674 | 1924189 | 0.33% | 股份 |
| Pentwater Capital Management LP | $777228100 | 1870000 | 0.32% | 买入期权 |
| Legal & General Group Plc | $771950431 | 1857302 | 0.32% | 股份 |
| HSBC HOLDINGS PLC | $751372125 | 1802500 | 0.31% | 卖出期权 |
| MILLENNIUM MANAGEMENT LLC | $672345116 | 1617653 | 0.28% | 股份 |
| GOLDMAN SACHS GROUP INC | $636389783 | 1531145 | 0.26% | 股份 |
| MARSHFIELD ASSOCIATES | $634316697 | 1526157 | 0.26% | 股份 |
| UBS Group AG | $621815730 | 1496080 | 0.26% | 股份 |
| RHUMBLINE ADVISERS | $607608189 | 1461895 | 0.25% | 股份 |
| Ensign Peak Advisors, Inc | $599888338 | 1443323 | 0.25% | 股份 |
| Qube Research & Technologies Ltd | $584349595 | 1405937 | 0.24% | 股份 |
| Caisse de depot et placement du Quebec | $566755977 | 1363607 | 0.23% | 股份 |
| AMERICAN CENTURY COMPANIES INC | $566576841 | 1363176 | 0.23% | 股份 |
| Assenagon Asset Management S.A. | $542834808 | 1306053 | 0.22% | 股份 |
| 1832 Asset Management L.P. | $537572517 | 1293392 | 0.22% | 股份 |
| LPL Financial LLC | $531650741 | 1279144 | 0.22% | 股份 |
| Davis Selected Advisers | $529839298 | 1274650 | 0.22% | 股份 |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | $528071215 | 1270532 | 0.22% | 股份 |
| WOLVERINE TRADING, LLC | $512799408 | 1485600 | 0.21% | 卖出期权 |
| HSBC HOLDINGS PLC | $508842509 | 1224268 | 0.21% | 股份 |
| FIL Ltd | $462416638 | 1112568 | 0.19% | 股份 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $461418710 | 1110167 | 0.19% | 股份 |
| Ninety One UK Ltd | $458593637 | 1103370 | 0.19% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $456902059 | 1099300 | 0.19% | 买入期权 |
| Nuveen Asset Management, LLC | $449500757 | 888587 | 0.18% | 股份 |
| Veritas Asset Management LLP | $448132682 | 1078201 | 0.18% | 股份 |
| NAYA CAPITAL MANAGEMENT UK LTD | $436832118 | 1051012 | 0.18% | 股份 |
| NEUBERGER BERMAN GROUP LLC | $435590401 | 1047589 | 0.18% | 股份 |
| MACKENZIE FINANCIAL CORP | $431689943 | 1038640 | 0.18% | 股份 |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $430280958 | 1035250 | 0.18% | 股份 |
| CTC LLC | $424566045 | 10215 | 0.17% | 卖出期权 |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $411538954 | 990157 | 0.17% | 股份 |
| NEW YORK STATE COMMON RETIREMENT FUND | $408705604 | 983340 | 0.17% | 股份 |
| JANE STREET GROUP, LLC | $402713051 | 968922 | 0.17% | 股份 |
| CITADEL ADVISORS LLC | $400319438 | 963163 | 0.16% | 股份 |
| CTC LLC | $395596634 | 9518 | 0.16% | 买入期权 |
| Fayez Sarofim & Co | $394573729 | 949339 | 0.16% | 股份 |
| D. E. Shaw & Co., Inc. | $382462726 | 920200 | 0.16% | 卖出期权 |
| GOLDMAN SACHS GROUP INC | $375355453 | 903100 | 0.15% | 卖出期权 |
| MILLENNIUM MANAGEMENT LLC | $372529169 | 896300 | 0.15% | 卖出期权 |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $366901369 | 1355931 | 0.15% | 股份 |
| Allen Investment Management, LLC | $364199528 | 876259 | 0.15% | 股份 |
| FIRST MANHATTAN CO. LLC. | $360530629 | 867432 | 0.15% | 股份 |
| PRUDENTIAL FINANCIAL INC | $359505403 | 864965 | 0.15% | 股份 |
| Longview Partners (Guernsey) LTD | $350167028 | 842497 | 0.14% | 股份 |
| W1M Asset Management Ltd | $349962345 | 842562 | 0.14% | 股份 |
| AVIVA PLC | $347327444 | 835665 | 0.14% | 股份 |
| Point72 Asset Management, L.P. | $345328264 | 830855 | 0.14% | 股份 |
| TD Asset Management Inc | $337496548 | 812012 | 0.14% | 股份 |
| TORONTO DOMINION BANK | $337017326 | 810859 | 0.14% | 股份 |
| PineStone Asset Management Inc. | $335630369 | 807522 | 0.14% | 股份 |
| JENNISON ASSOCIATES LLC | $335325296 | 806788 | 0.14% | 股份 |
| PeakShares LLC | $329595000 | 793 | 0.14% | 股份 |
| US BANCORP \DE\ | $328365156 | 790042 | 0.13% | 股份 |
| JONES FINANCIAL COMPANIES LLLP | $325830242 | 761481 | 0.13% | 股份 |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $320418726 | 770923 | 0.13% | 股份 |
| Clearbridge Investments, LLC | $312811372 | 752620 | 0.13% | 股份 |
| Robeco Institutional Asset Management B.V. | $311375867 | 749166 | 0.13% | 股份 |
公司内部人士 64 位内幕人士 · 37 位高管 · 27 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Timothy John Noel | Chief Executive Officer, UHC | 2026年6月23日 A | 17651 | 0 | 0 | $0 |
| Stephen J Hemsley | CEO, UHG | 2026年6月23日 A | 48099 | 0 | 0 | $0 |
| Heather Cianfrocco | Chief Executive Officer, Optum | 2025年3月18日 A | 22438 | 0 | 0 | $0 |
| Andrew Witty | CEO, UHG | 2025年3月18日 A | 112162 | 0 | 0 | $0 |
| Brian R Thompson | CEO, UnitedHealthcare | 2024年9月24日 A | 32675 | 0 | 0 | $0 |
| David S Wichmann | Chief Executive Officer | 2020年12月16日 F | 967872 | 0 | 0 | $0 |
| Steven H Nelson | EVP & CEO, UnitedHealthcare | 2019年6月25日 A | 38502 | 0 | 0 | $0 |
| Larry C Renfro | Vice Chmn, UHG and CEO, Optum | 2018年6月26日 A | 153790 | 0 | 0 | $0 |
| Gail Boudreaux | EVP & CEO, UnitedHealthcare | 2014年9月23日 A | 184732 | 0 | 0 | $0 |
| George Lawrence Mikan III | EVP UHG & CEO, Optum | 2011年6月5日 F | 209279 | 0 | 0 | $0 |
| Tracy L Bahl | CEO, Uniprise | 2006年11月7日 A | 4230 | 0 | 0 | $0 |
| Robert J Sheehy | CEO, UnitedHealthcare | 2006年11月7日 A | 3009 | 0 | 0 | $0 |
| MCGUIRE WILLIAM W | Chief Executive Officer | 2006年11月7日 A | 644862 | 0 | 0 | $0 |
| Channing R Wheeler | CEO, Uniprise, Inc. | 2003年11月28日 J | 8356 | 0 | 0 | $0 |
| Wayne S Deveydt | Chief Financial Officer | 2026年6月23日 A | 19779 | 0 | 0 | $0 |
| John F Rex | President & CFO | 2025年6月24日 A | 203898 | 0 | 0 | $0 |
| Patrick J Erlandson | Chief Financial Officer | 2006年5月2日 A | 7083 | 0 | 0 | $0 |
| Dirk C Mcmahon | President & COO, UHG | 2024年3月19日 A | 70547 | 0 | 0 | $0 |
| Christopher R Zaetta | EVP & Chief Legal Officer | 2026年6月23日 A | 15860 | 0 | 0 | $0 |
| Erin Mcsweeney | EVP & Chief People Officer | 2026年6月23日 A | 15601 | 0 | 0 | $0 |
| Thomas E Roos | Chief Accounting Officer | 2026年2月23日 A | 31284 | 0 | 0 | $0 |
| Rupert M Bondy | EVP & Chief Legal Officer | 2024年3月19日 A | 9607 | 0 | 0 | $0 |
| Marianne D Short | EVP & Chief Legal Officer | 2022年2月25日 F | 138315 | 0 | 0 | $0 |
| Patricia L Lewis | EVP and Chief HR Officer | 2022年2月13日 F | 8901 | 0 | 0 | $0 |
| Ellen D Wilson | Executive Vice President | 2020年3月24日 A | 58387 | 0 | 0 | $0 |
| Eric S Rangen | Sr VP & Chief Acctg Officer | 2015年6月24日 A | 11577 | 0 | 0 | $0 |
| Lori Sweere | EVP, Human Capital | 2013年5月10日 S | 70661 | 0 | 0 | $0 |
| Richard N Baer | EVP & Chief Legal Officer | 2012年12月28日 F | 63880 | 0 | 0 | $0 |
| Reed Vaughn Tuckson | EVP & Chief of Medical Affairs | 2012年6月5日 F | 116886 | 0 | 0 | $0 |
| William A Munsell | EVP, UnitedHealth Group | 2012年6月5日 F | 268167 | 0 | 0 | $0 |
| Anthony Welters | EVP, UnitedHealth Group | 2012年6月5日 F | 119909 | 0 | 0 | $0 |
| Christopher James Walsh | EVP and General Counsel | 2011年5月24日 A | 101338 | 0 | 0 | $0 |
| Mitchell Eliot Zamoff | EVP and General Counsel | 2011年5月24日 A | 113613 | 0 | 0 | $0 |
| Thomas L Strickland | EVP & Chief Legal Officer | 2008年6月5日 A | 147182 | 0 | 0 | $0 |
| Richard H Anderson | EVP, Pres, Commercial Svcs Grp | 2007年5月28日 A | 40606 | 0 | 0 | $0 |
| Lois E Quam | EVP & Pres, Pub & Sr Mkt Grp | 2007年5月28日 A | 13915 | 0 | 0 | $0 |
| Forrest Gregory Burke | Acting General Counsel | 2007年4月17日 A | — | 0 | 0 | $0 |
| Frederick William Mcnabb III | 董事 | 2026年7月1日 A | 15462 | 0 | 0 | $0 |
| Kristen Gil | 董事 | 2026年7月1日 A | 2617 | 0 | 0 | $0 |
| Rice Valerie Montgomery MD | 董事 | 2026年7月1日 A | 7876 | 0 | 0 | $0 |
| John H Noseworthy | 董事 | 2026年7月1日 A | 7616 | 0 | 0 | $0 |
| Charles D. Baker | 董事 | 2026年7月1日 A | 2396 | 0 | 1 | $-9613 |
| Timothy Patrick Flynn | 董事 | 2026年7月1日 A | 10875 | 0 | 0 | $0 |
| Scott Gottlieb | 董事 | 2026年7月1日 A | 659 | 0 | 0 | $0 |
| Paul R Garcia | 董事 | 2026年7月1日 A | 3906 | 0 | 0 | $0 |
| Michele J Hooper | 董事 | 2026年4月1日 A | 41792 | 0 | 0 | $0 |
| BURKE RICHARD T | 董事 | 2022年5月19日 S | 1215000 | 0 | 0 | $0 |
| Gail R Wilensky | 董事 | 2022年4月1日 A | 24690 | 0 | 0 | $0 |
| Glenn M Renwick | 董事 | 2021年4月1日 A | 85130 | 0 | 0 | $0 |
| BALLARD WILLIAM C JR | 董事 | 2020年4月1日 A | 62266 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士;净额=仅公开市场买卖
激进投资者及 5%+ 股东 2 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权,意图影响发行人(激进股东持股、董事会活动、并购)。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| UnitedHealth Group Incorporated ×3 申报 | 2021年1月15日 | — | 初始申报 | 并购/出售 | SEC |
| Ingenix, Inc., UnitedHealth Group Incorporated | 2006年6月5日 | — | 初始申报 | 并购/出售 | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF持仓 由 278 只交易所交易基金持有
权重仅反映直接股权持仓(N-PORT);杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
| 基金 | 权重 | 单位 | 截至 | 来源 |
|---|---|---|---|---|
| IHF · iShares Trust | 20.01% | 634654 SH | 2026年8月21日 | 每日 |
| DJD · Invesco Exchange-Traded Fund Trust | 7.73% | 101155 SH | 2026年8月21日 | 每日 |
| JDOC · J.P. Morgan Exchange-Traded Fund ... | 5.83% | 1751 NS | 2026年4月30日 | N-PORT |
| VHT · VANGUARD WORLD FUND | 5.56% | 2728542 SH | 2026年8月19日 | 每日 |
| FHLC · FIDELITY COVINGTON TRUST | 5.42% | 417583 NS | 2026年4月30日 | N-PORT |
| IYH · iShares Trust | 5.37% | 538654 SH | 2026年8月21日 | 每日 |
| HRTS · Tema ETF Trust | 5.24% | 7159 NS | 2026年5月31日 | N-PORT |
| FLAG · Global X Funds | 5.12% | 228 NS | 2026年4月30日 | N-PORT |
| SCHD · SCHWAB STRATEGIC TRUST | 5.09% | 12713822 NS | 2026年5月31日 | N-PORT |
| RXL · ProShares Trust | 4.98% | 9446 NS | 2026年5月31日 | N-PORT |
| DOGG · First Trust Exchange-Traded Fund IV | 4.95% | 8762 NS | 2026年4月30日 | N-PORT |
| CURE · Direxion Shares ETF Trust | 4.84% | 18062 NS | 2026年4月30日 | N-PORT |
| DJIA · Global X Funds | 4.63% | 21113 NS | 2026年4月30日 | N-PORT |
| DYLG · Global X Funds | 4.61% | 732 NS | 2026年4月30日 | N-PORT |
| VEGN · ETF Series Solutions | 4.22% | 17678 NS | 2026年4月30日 | N-PORT |
| GFGF · EA Series Trust | 3.98% | 3881 NS | 2026年5月29日 | N-PORT |
| IXJ · iShares Trust | 3.79% | 428796 SH | 2026年8月21日 | 每日 |
| EQIN · Columbia ETF Trust I | 3.65% | 27252 NS | 2026年4月30日 | N-PORT |
| LGRO · ALPS ETF Trust | 3.45% | 12238 NS | 2026年5月31日 | N-PORT |
| JXX · Janus Detroit Street Trust | 3.34% | 3270 NS | 2026年4月30日 | N-PORT |
| EDOW · First Trust Exchange-Traded Fund | 3.32% | 24460 NS | 2026年6月30日 | N-PORT |
| DDM · ProShares Trust | 3.30% | 45359 NS | 2026年5月31日 | N-PORT |
| PRVS · Parnassus Funds II | 3.25% | 1978 NS | 2026年6月30日 | N-PORT |
| BKDV · BNY Mellon ETF Trust II | 3.14% | 117081 NS | 2026年4月30日 | N-PORT |
| PWV · Invesco Exchange-Traded Fund Trust | 3.10% | 149362 SH | 2026年8月21日 | 每日 |
| QLTY · GMO ETF Trust | 2.85% | 337119 NS | 2026年5月31日 | N-PORT |
| AVIE · AMERICAN CENTURY ETF TRUST | 2.72% | 735 NS | 2026年5月31日 | N-PORT |
| FMCX · Northern Lights Fund Trust IV | 2.67% | 8276 NS | 2026年5月31日 | N-PORT |
| FMCE · Northern Lights Fund Trust IV | 2.67% | 4741 NS | 2026年5月31日 | N-PORT |
| CBLS · Elevation Series Trust | 2.65% | 3800 NS | 2026年4月30日 | N-PORT |
| UDOW · ProShares Trust | 2.52% | 55671 NS | 2026年5月31日 | N-PORT |
| TBG · EA Series Trust | 2.51% | 15609 NS | 2026年4月30日 | N-PORT |
| ESN · Northern Lights Fund Trust II | 2.47% | 18098 NS | 2026年5月31日 | N-PORT |
| OMAH · Tidal Trust III | 2.46% | 49724 NS | 2026年4月30日 | N-PORT |
| SNPV · DBX ETF Trust | 2.35% | 14245 NS | 2026年5月29日 | N-PORT |
| PALC · Pacer Funds Trust | 2.35% | 14601 NS | 2026年4月30日 | N-PORT |
| FMED · Fidelity Covington Trust | 2.25% | 2424 NS | 2026年5月31日 | N-PORT |
| PY · Principal Exchange-Traded Funds | 2.11% | 11168 NS | 2026年6月30日 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trus... | 2.09% | 539098 SH | 2026年8月21日 | 每日 |
| SFYF · Tidal Trust I | 2.08% | 2389 NS | 2026年5月31日 | N-PORT |
| FLV · AMERICAN CENTURY ETF TRUST | 2.07% | 19236 NS | 2026年5月31日 | N-PORT |
| HGRO · ETF Opportunities Trust | 2.06% | 5413 NS | 2026年4月30日 | N-PORT |
| CGDV · Capital Group Dividend Value ETF | 2.02% | 1872479 NS | 2026年5月31日 | N-PORT |
| GMOV · GMO ETF Trust | 2.02% | 4839 NS | 2026年5月31日 | N-PORT |
| DUSA · Davis Fundamental ETF Trust | 1.96% | 61270 NS | 2026年4月30日 | N-PORT |
| GVIP · Goldman Sachs ETF Trust | 1.84% | 27590 NS | 2026年5月31日 | N-PORT |
| MGV · VANGUARD WORLD FUND | 1.78% | 570801 SH | 2026年8月19日 | 每日 |
| MEDI · Harbor ETF Trust | 1.77% | 1315 NS | 2026年4月30日 | N-PORT |
| CAPE · DoubleLine ETF Trust | 1.72% | 9864 NS | 2026年6月30日 | N-PORT |
| VIG · VANGUARD SPECIALIZED FUNDS | 1.65% | 5130541 SH | 2026年8月19日 | 每日 |